CHEBI:231614 - Nivolumab

ChEBI IDCHEBI:231614
ChEBI NameNivolumab
Stars
DefinitionNivolumab is a human monoclonal antibody for Programmed Death Receptor-1 (PD-1). It is a targeted immunotherapy treatment against metastatic cancer.
Submitteramillett1
ChEBI Ontology
Outgoing Relation(s)
Nivolumab (CHEBI:231614) is a organic molecular entity (CHEBI:50860)
Synonym  Source
Anti-PD-1 human monoclonal antibody MDX-1106SUBMITTER
Registry NumbersSources
CAS:946414-94-4SUBMITTER